Table 2. Multiple linear regression model of the onset latency of upper trapezius and middle trapezius, adjusted by the additive combination of the variables: body mass index, percentage of body fat, skinfolds, and fatigue in no-fatigue (n = 17) and fatigue (n = 17) groups.
| R2 | β | P | 95% CI | |||
|---|---|---|---|---|---|---|
| Upper Trapezius Onset Latency | Model 1 - Body Mass Index | 0.08 | −37.6 | 0.071 | −78.7 | 3.4 |
| Model 2 - Body Fat percentage | 0.10 | 1.0 | 0.796 | −7.3 | 9.4 | |
| Model 3 - Axillary Skinfold | 0.11 | 2.4 | 0.517 | −5.1 | 9.9 | |
| Model 4 - Fatigue | 0.13 | −13.6 | 0.357 | −43.5 | 16.2 | |
| Model 1 - Body Mass Index | 0.08 | −32.6 | 0.089 | −70.6 | 5.3 | |
| Model 2 - Body Fat percentage | 0.10 | 3.6 | 0.318 | −3.7 | 11.1 | |
| Model 3 - Pectoral Skinfold | 0.10 | −1.1 | 0.661 | −6.1 | 3.9 | |
| Model 4 - Fatigue | 0.13 | −12.2 | 0.405 | −41.8 | 17.3 | |
| Model 1 - Body Mass Index | 0.08 | −31.2 | 0.112 | −70.1 | 7.7 | |
| Model 2 - Body Fat percentage | 0.10 | 3.4 | 0.356 | −4.0 | 10.9 | |
| Model 3 - Subscapular Skinfold | 0.11 | −0.8 | 0.767 | −6.8 | 5.1 | |
| Model 4 - Fatigue | 0.12 | −8.3 | 0.573 | −38.1 | 21.5 | |
| Middle Trapezius Onset Latency | Model 1 - Body Mass Index | 0.00 | −36.7 | 0.130 | −85.1 | 11.5 |
| Model 2 - Body Fat percentage | 0.00 | −3.7 | 0.441 | −13.6 | 6.0 | |
| Model 3 - Axillary Skinfold | 0.27 | 9.5 | 0.035* | 0.7 | 18.4 | |
| Model 4 - Fatigue | 0.69 | 107.0 | 0.000* | 71.9 | 142.1 | |
| Model 1 - Body Mass Index | 0.00 | −15.9 | 0.502 | −63.7 | 31.9 | |
| Model 2 - Body Fat percentage | 0.00 | 2.0 | 0.658 | −7.3 | 11.4 | |
| Model 3 - Pectoral Skinfold | 0.06 | 1.6 | 0.610 | −4.8 | 8.0 | |
| Model 4 - Fatigue | 0.64 | 125.1 | 0.000* | 87.8 | 162.5 | |
| Model 1 - Body Mass Index | 0.00 | −22.0 | 0.357 | −70.2 | 26.1 | |
| Model 2 - Body Fatpercentage | 0.00 | 0.5 | 0.904 | −8.7 | 9.8 | |
| Model 3 - Subscapular Skinfold | 0.17 | 4.1 | 0.265 | −3.3 | 11.5 | |
| Model 4 - Fatigue | 0.65 | 114.1 | 0.000* | 77.2 | 151.0 | |
Notes.
significant difference (P < 0.05); 95% CI, 95% confidence interval.